Immunotech Laboratories, Inc. is a drug development company. It engages in the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The company was founded on April 11, 2000 and is headquartered in Monrovia, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company